StockWatch
·
Biotechnology: Pharmaceutical Preparations
AcquisitionsAug 3, 2026, 08:05 AM

Clearmind to acquire 51% stake in EV wireless charging co. for $2.5M

AI Summary

Clearmind Medicine Inc., a clinical-stage biotech company, announced it has entered into a non-binding Letter of Intent to acquire a 51% stake in a leading intelligent EV wireless charging solutions company. The acquisition is valued at $2.5 million, with an additional $1.5 million loan to be extended to the acquired company at 4% interest. This strategic move diversifies Clearmind's portfolio beyond its core focus on neuroplastogen-derived therapeutics.

Key Highlights

  • Clearmind signed a non-binding LOI to acquire a 51% stake in an intelligent EV wireless charging solutions company.
  • The acquired company develops wireless charging for automated parking systems and autonomous mobile platforms.
  • The acquisition purchase price for the majority stake is $2.5 million.
  • Clearmind will extend a $1.5 million loan to the acquired company.
  • The loan bears interest at 4% per annum and is repayable on the two-year anniversary of closing.
  • The acquisition is subject to definitive agreements, due diligence, and closing conditions.